Updated:
Deerfield Capital Management
Deerfield Capital Management was established in 1995 by James E. Buckman.
Deerfield Capital Management
Deerfield Capital Management was established in 1995 by James E. Buckman. The firm manages capital generated by the Buckman family's involvement in the paper and packaging sector, notably through ties to Kimberly-Clark. It operates as a single-family office with a healthcare investment focus. The firm invests across the capital structure, including private equity, venture capital, public equities, and real estate. Its healthcare strategy targets therapeutics, diagnostics, and life sciences tools, often taking large minority or controlling stakes. Known positions have included investments in biotechnology and pharmaceutical companies such as Sarepta Therapeutics and bluebird bio (per SEC filings, 2020). Geographic focus is primarily North America, with selective European opportunities. Deerfield runs a lean investment team and maintains additional offices in New York, Princeton, Chicago, and Austin. The firm also manages philanthropic initiatives through the Deerfield Foundation, supporting medical research and education. Its permanent capital base frees it from fundraising cycles, a structure that shapes its long-duration approach. A structural differentiator is Deerfield's integrated model: it combines direct family capital with separately managed accounts for certain institutional partners, blending family office control with asset-management flexibility. This hybrid lets it act like an operating company in complex healthcare deals without external fund constraints.
General information
Firm type
Single Family Office
Year founded
1995
AUM
$10B - $20B (Altss estimate)
Location
Region
North America
Country
United States
City
Neenah
Corporate office
Neenah, WI, United States
Additional offices
New York · Princeton · Chicago · Austin
Principals
James E. Buckman
President and Chief Investment Officer
David J. M. Huth
Managing Director
Sector focus
Frequently asked questions
Who runs investment decisions at Deerfield Capital Management?
James E. Buckman serves as President and Chief Investment Officer, leading the firm since its founding in 1995. David J. M. Huth is a Managing Director, co-steering healthcare private equity investments. The firm has a small senior team, with decisions concentrated at the top.
How does Deerfield's permanent capital base affect its investment strategy?
Because Deerfield invests its own family capital permanently, it avoids the fundraising and exit pressures that constrain typical healthcare funds. That allows it to hold positions for a decade or longer, take concentrated bets on early-stage biotech, and structure deals with complex milestone payments that traditional LPs might avoid.
Does Deerfield invest only in healthcare?
Healthcare is the dominant focus—spanning private equity, venture, and public stocks within biopharma, diagnostics, and life sciences tools. The firm also holds real estate assets in its home markets, but healthcare forms the core of its portfolio and public identity.
What is the relationship between Deerfield Capital and the Deerfield Foundation?
The Deerfield Foundation is a separately managed philanthropic vehicle funded by the family's wealth. It supports medical research, healthcare education, and community programs. The foundation operates with its own board and grant-making process, distinct from the investment office.
Is Deerfield a single-family office available to outside investors?
Deerfield is primarily a single-family office for the Buckman family. However, it has historically offered managed accounts to select institutional investors, leveraging the same platform and deal flow without commingling capital in a traditional fund structure. It generally does not solicit outside capital.
What is the firm's stance on co-investments with external GPs?
Deerfield co-invests directly alongside specialist healthcare venture and buyout firms when a deal aligns with its long-term thesis. The firm typically leads or participates in syndicated rounds, preferring sizable minority stakes rather than passive fund commitments.
Where does the underlying wealth of Deerfield come from?
The wealth originates from the Buckman family's involvement in the paper and packaging industry, particularly through ties to Kimberly-Clark Corporation. James E. Buckman built on that base to diversify into healthcare investing, but the family's industrial background remains the original capital source.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: